(Q50733068)

18 March 2018

title

Xpert MTB/RIF testing in a low tuberculosis incidence, high-resource setting: limitations in accuracy and clinical impact. (English)

1 reference

18 March 2018

1 reference

Gonzalo G Alvarez

6

0 references

Madhukar Pai

Madhukar Pai

9

0 references

Claudia Denkinger

10

Claudia M Denkinger

1 reference

18 March 2018

Dick Menzies

3

Dick Menzies

1 reference

18 March 2018

Marcel A Behr

4

Marcel Behr

1 reference

18 March 2018

Kevin Schwartzman

5

Kevin Schwartzman

1 reference

18 March 2018

author name string

Hojoon Sohn

1

1 reference

18 March 2018

Abebech D Aero

2

1 reference

18 March 2018

Andrei Dan

7

1 reference

18 March 2018

Fiona McIntosh

8

1 reference

18 March 2018

language of work or name

English

0 references

publication date

14 January 2014

1 reference

18 March 2018

Clinical Infectious Diseases

published in

1 reference

18 March 2018

volume

58

1 reference

18 March 2018

issue

7

1 reference

18 March 2018

page(s)

970-976

1 reference

18 March 2018

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU022

Comparison of the Xpert MTB/RIF test with an IS6110-TaqMan real-time PCR assay for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU022

Effectiveness of an integrated real-time PCR method for detection of the Mycobacterium tuberculosis complex in smear-negative extrapulmonary samples in an area of low tuberculosis prevalence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU022

Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU022

A systematic review of delay in the diagnosis and treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU022

Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU022

Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU022

Implementation of Xpert MTB/RIF for routine point-of-care diagnosis of tuberculosis at the primary care level

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU022

Point-of-care Xpert® MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU022

Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU022

Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU022

Comparison of time to positive and colony counting in an early bactericidal activity study of anti-tuberculosis treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU022

False-positive rifampicin resistance on Xpert® MTB/RIF: case report and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU022

Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU022

Diagnostic implications of inconsistent results obtained with the Xpert MTB/Rif assay in detection of Mycobacterium tuberculosis isolates with an rpoB mutation associated with low-level rifampin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU022

Rifampin drug resistance tests for tuberculosis: challenging the gold standard

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU022

Cost-effectiveness of Xpert® MTB/RIF for diagnosing pulmonary tuberculosis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU022

21 January 2018

Identifiers

DOI

10.1093/CID/CIU022

1 reference

18 March 2018

PubMed ID

24429440

1 reference

18 March 2018